14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Predictions

NASDAQ Stock Exchange
Open Broker Account
$38.22
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 25 Apr 2024

DRNA Predictions History

4 years ago
 NameNotImportant predicted that DRNA for 2019-04-29 is going $13.00 (-2.33%)

5 years ago
 NameNotImportant predicted that DRNA for 2019-04-23 is going $14.54 (3.93%)

6 years ago
 JS predicted that DRNA for 2017-11-17 is going $9.55 (0.10%)

6 years ago
 JuanC Villegas predicted that DRNA for 2017-10-11 is going $5.62 (-2.77%)

6 years ago
 JS predicted that DRNA for 2017-10-11 is going $5.60 (-3.11%)

Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT